Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells

被引:14
作者
Jougasaki, M
Larsen, AM
Cataliotti, A
Christiansen, DC
Burnett, JC
机构
[1] Natl Hosp Kyushu Cardiovasc Ctr, Inst Clin Res, Kagoshima 8920853, Japan
[2] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA
关键词
endothelium; hormone; immunocytochemistry; peptides; radioimmunoassay;
D O I
10.1016/S0196-9781(02)00078-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-1 (ET-1) is a vasoconstricting and mitogenic peptide released from vascular endothelial cells under normal and pathophysiological conditions, and synthesis and secretion of ET-1 are stimulated by cytokines. Cardiotrophin-1 (CT-1) is a new member of the interleukin-6-type cytokines that induce biological actions through the glycoprotein (gp) 130. The present study was designed to determine the presence of CT-1 and the gp 130 cytokine system in vascular endothelial cells and to investigate whether CT-1 stimulates synthesis and secretion of ET-1 in the vascular endothelial cells. We first sought to determine gene expression and immunoreactivity of CT-1, gp 130 and ET-1 in cultured canine aortic endothelial cells (CAECs) using Northern blot analysis and immunocytochemistry, which revealed the presence of CT-1 and gp 130 together with ET-1 in CAECs. CT-1 increased ET-1 gene expression in CAECs, and stimulated ET-1 secretion from CAECs in a dose-dependent manner. Furthermore, inhibition of gp 130 by monoclonal antibody attenuated ET-1 secretion from CAECs, suggesting that actions of CT-1 on the secretion of ET-1 are mediated through gp 130 receptor system. The present study, therefore, reports the presence of CT-1 and gp 130 in vascular endothelial cells and mechanisms of secretion of ET-1 related to this cytokine system. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1441 / 1447
页数:7
相关论文
共 24 条
[1]   The heart is a source of circulating cardiotrophin-1 in humans [J].
Asai, S ;
Saito, Y ;
Kuwahara, K ;
Mizuno, Y ;
Yoshimura, M ;
Higashikubo, C ;
Tsuji, T ;
Kishimoto, I ;
Harada, M ;
Hamanaka, I ;
Takahashi, N ;
Yasue, H ;
Nakao, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :320-323
[2]  
Harada M, 1997, CIRCULATION, V96, P3737
[3]   MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130 [J].
HIBI, M ;
MURAKAMI, M ;
SAITO, M ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
CELL, 1990, 63 (06) :1149-1157
[4]   CONTINUOUS ACTIVATION OF GP130, A SIGNAL-TRANSDUCING RECEPTOR COMPONENT FOR INTERLEUKIN 6-RELATED CYTOKINES, CAUSES MYOCARDIAL HYPERTROPHY IN MICE [J].
HIROTA, H ;
YOSHIDA, K ;
KISHIMOTO, T ;
TAGA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4862-4866
[5]   cDNA cloning of rat cardiotrophin-1 (CT-1): Augmented expression of CT-1 gene in ventricle of genetically hypertensive rats [J].
Ishikawa, M ;
Saito, Y ;
Miyamoto, Y ;
Kuwahara, K ;
Ogawa, E ;
Nakagawa, O ;
Harada, M ;
Masuda, I ;
Nakao, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :377-381
[6]   Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin [J].
Jougasaki, M ;
Schirger, JA ;
Simari, RD ;
Burnett, JC .
HYPERTENSION, 1998, 32 (05) :917-922
[7]   Augmented cardiac cardiotrophin-1 in experimental congestive heart failure [J].
Jougasaki, M ;
Tachibana, I ;
Luchner, A ;
Leskinen, H ;
Redfield, MM ;
Burnett, JC .
CIRCULATION, 2000, 101 (01) :14-17
[8]   CYTOKINE SIGNAL-TRANSDUCTION [J].
KISHIMOTO, T ;
TAGA, T ;
AKIRA, S .
CELL, 1994, 76 (02) :253-262
[9]  
Kowala M C, 1997, Adv Pharmacol, V37, P299
[10]   Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes [J].
Kunisada, K ;
Hirota, H ;
Fujio, Y ;
Matsui, H ;
Tani, Y ;
YamauchiTakihara, K ;
Kishimoto, T .
CIRCULATION, 1996, 94 (10) :2626-2632